Tick season is the worst it has been in years. Here is the part that surprises people: a great deal of the lasting harm from a tick bite comes not from the bug itself, but from the way the body reacts to it. Inflammation that will not switch off, an immune system stuck in overdrive, over-reactive allergy cells, and the pain, brain fog, and exhaustion that can drag on for months.
The encouraging part is that your body already runs a system built to manage exactly those reactions, and most people have never heard of it.
It is a balancing network you were born with. A few things worth knowing before anything else:
Because this system governs the very processes a tick bite disturbs, supporting it with the right cannabinoids from the hemp plant may help the body:
What follows is the why behind each of these, in plain language.
Tick populations across the United States are expanding, and 2026 has been one of the worst seasons on record. Reported tick-related emergency visits are the highest for this time of year since 2017, with almost every region affected. The reasons are environmental: warmer winters that let ticks survive, an earlier start to the season, and growing deer and wildlife populations that carry ticks into new areas. An estimated 31 million Americans are bitten by a tick each year, and roughly 476,000 are treated for Lyme disease alone.
The result is that more people, in more places, are meeting these illnesses for the first time. That matters, because the early signs are easy to miss, and a tick can pass on far more than Lyme.
A single bite can carry more than one organism, and they span the full range of germs. This is part of what makes tick-borne illness so confusing to recognise.
| Type | Illness | In plain terms |
|---|---|---|
| Bacteria | Lyme disease | The most common by far, around 476,000 treated cases a year, carried mainly by deer ticks. |
| Bacteria | Anaplasmosis, ehrlichiosis | Sudden feverish illnesses that usually respond well when caught early. |
| Bacteria | Rocky Mountain spotted fever | Less common but serious, and can turn dangerous within days if missed. |
| Parasite | Babesiosis | A malaria-like infection of the red blood cells. Often shows up alongside Lyme. |
| Virus | Powassan virus | Rare but severe, can inflame the brain, and has no specific cure. |
| Virus | Heartland, Bourbon, Colorado tick fever | Newer or regional viruses still being studied. |
The bacterial ones are the most common and the most manageable when caught early. The viral ones are rarer but can be the most dangerous, and several have no specific cure, which leaves supporting the body as the main option. The parasites often travel with Lyme, because they share the same tick.
One of the strangest things a tick can do is not an infection at all. Alpha-gal syndrome is an allergy to a sugar found in red meat and other mammal products. A bite, usually from the lone star tick, can sensitise the immune system to that sugar. After that, eating beef, pork, dairy, or even some medication coatings can set off a reaction.
The tricky part is the timing: reactions are usually delayed by two to six hours, so people rarely connect a night-time bout of hives, or worse, to a meal eaten earlier in the day. It can range from itching and stomach upset to a severe, whole-body allergic reaction. There is no cure, only avoidance, although sensitivity can fade if further bites are prevented. As many as 450,000 Americans may be affected. Alpha-gal matters here for one reason: it is driven by the same allergy cells, the mast cells, that the endocannabinoid system helps to keep in check.
For most people a tick-borne infection clears. But a meaningful number, in the case of Lyme somewhere between one in ten and one in five, are left with symptoms that drag on long after the infection has been dealt with: deep fatigue, widespread aches, poor sleep, and a stubborn mental fog. The leading explanations are not the germ still being present, but the body's response staying switched on: inflammation that will not settle, an immune system that stays activated, and a nervous system that has become over-sensitive to pain.
This is the heart of the matter. The damage that lingers is largely about how the body reacts, and how the body reacts is exactly what the endocannabinoid system is built to regulate.
The endocannabinoid system is the body's own balancing network. Its job is to nudge other systems back toward steady when they get pushed out of line, and it is busiest exactly where the body is fighting to restore balance, which in tick-borne illness means the immune system and the nervous system.
It has three parts: receptors (the best known are CB1, found mostly in the brain and nerves, and CB2, found mostly in immune tissue), the body's own signalling molecules that switch those receptors on, and the enzymes that build and clear those molecules. The overall level of activity is often called endocannabinoid tone, and low tone has been linked to several stubborn conditions of pain and fatigue. Cannabinoids from the hemp plant work with this same system, some by gently raising the body's own signals, others by acting at a panel of related targets. Because the system touches immunity, inflammation, pain, mood, and sleep all at once, it is a natural fit for an illness that disturbs all of those at once.
The case is not built on one mechanism. It rests on the fact that four of the processes that cause harm in tick-borne illness are each, on their own, processes this system is known to regulate.
The nervous-system form of Lyme inflames the brain, and that inflammation, rather than the bug itself, is increasingly seen as the cause of the fog, mood changes, and memory trouble. The CB2 receptor sits on the brain's own immune cells and helps switch them from an inflamed state toward a calmer one. This is the same lever studied in other inflammatory brain conditions, and in principle it is the one that matters for the fog of Lyme.
Much of how ill a person feels comes from inflammatory signals the immune system pumps out. The endocannabinoid system tends to tune that response toward balance rather than simply switching it off, which is the point: in an illness you do not want the defences shut down, you want them brought back under control. Several hemp cannabinoids have shown this kind of calming, balancing effect on immune cells in the laboratory.
Alpha-gal, and the flares many people with chronic tick illness report, run through the mast cells, the cells that release histamine in an allergic reaction. The endocannabinoid system helps keep these cells from over-firing. The body's own signals and the related compound PEA have the clearest steadying effect here. The picture for CBD specifically is more mixed, which is worth being honest about, so a mast-cell-driven problem may call for PEA rather than CBD.
The lingering symptoms after Lyme look a lot like fibromyalgia: widespread pain, exhaustion, broken sleep, and fog with no clear single cause. There is a well-developed idea that conditions like these involve a shortfall in endocannabinoid tone, and that topping it up is why cannabinoids so often help where ordinary painkillers do not. For the person left worn down after the infection is gone, this is the part that speaks most directly to daily life.
These are the compounds from hemp whose known effects line up with the four points above. The guiding idea is breadth: several compounds working across several targets, rather than one molecule doing one job.
The broadest all-rounder, with the most research behind its anti-inflammatory and calming effects, and a gentle lift to the body's own endocannabinoid signals. The one caution is its uneven behaviour at the allergy cells, noted above.
Minor cannabinoids with anti-inflammatory activity and, for CBG, early signals for mood and stress. Both reinforce the calming, balancing side.
Most often of interest for the sleep that tick illness so often wrecks, though the human evidence here is still thin.
Not a hemp cannabinoid but a compound the body makes itself, and the single best-studied for steadying mast cells and calming nerve inflammation. It has decades of use for nerve pain and an excellent safety record, and it is the natural partner to the hemp cannabinoids where allergy or alpha-gal is the main problem.
This is a promising idea built on solid biology, and it should be read as exactly that, not more. The strong claim it supports is that the endocannabinoid system regulates the very processes, inflammation, immune balance, allergy cells, pain, and sleep, that cause so much of the suffering in tick-borne illness, and that hemp cannabinoids act on each of those processes.
There is also a second strand worth knowing about, because it is easy to under-sell. In laboratory research, cannabinoids from hemp have shown direct activity against bacteria, viruses, and fungi, including drug-resistant ones, often by attacking the microbe's own membrane. Reviews now describe this activity across all of these groups, and the hemp plant has been studied as a possible source of new antibiotics. This is real and genuinely promising. Two things keep it in proportion, though: it is still mostly laboratory and animal work rather than proven in people, and it is largely a separate effect from the endocannabinoid balancing that is this document's main subject, the compound acting on the germ directly rather than through the body's own system.
And one honest limit holds throughout. There is no large human trial of cannabinoids in Lyme disease, alpha-gal, or the lingering symptoms that follow, and much of the supporting human evidence is borrowed from closely related conditions such as fibromyalgia, which is helpful but not the same as direct proof. So however promising the laboratory antimicrobial findings are, they are not, on today's evidence, a reason to manage a serious tick-borne illness with hemp on its own. If you suspect a tick-borne illness, or you have an allergic reaction, that needs proper medical care without delay, and everything here is meant to sit alongside that, never in place of it.
To keep the science above standing on its own, one point of clarity: we make no antimicrobial or disease-treatment claims for our formulations. We do not position them, or sell them, as something that kills the bacteria, parasites, or viruses behind tick-borne disease, and they are not a treatment for any infection. What they are built to do is support the body by activating the endocannabinoid system, the balancing network described throughout this document. They come in three forms, each a different way of delivering that support.
Held under the tongue and absorbed into the bloodstream for steady, whole-body support. A broad blend led by CBD, with CBG, CBN, and the acidic cannabinoids CBDa and CBGa sitting on a full minor-cannabinoid base, around 79mg of cannabinoids per 1ml serving. Zero detectable THC.
Worked into the skin for support that stays local to one area, a sore joint or an irritated patch of skin. The lightweight Kaneh Bosom oil absorbs quickly and doubles as a massage medium; the firm beeswax salve is made for deep-tissue and trigger-point work and stays exactly where applied. Built on natural plant oils, zero THC, made in Texas.
Deliver the cannabinoids through the body's own absorptive tissue, which sidesteps the digestive route. This suits people who find oral products hard to tolerate and lets a fuller cannabinoid load reach the system. The aim, as with the others, is to feed the endocannabinoid system in the way that best fits the person.
The wider antimicrobial research mentioned above is about the hemp plant in general and is offered as background, not as a claim about any particular product of ours.